Table 1.
Device-related complications | |
Migration | Migration of any lead from the original placement site |
Erosion | Lead protruding through the skin |
Lead damage | Breakage, fracture, kink, or other damage |
Damage to sheath | Breakage, fracture, kink, or other damage |
Lead connection failure | Loose connection or disconnection |
Hardware malfunction | Battery failure, inoperable device, or IPG communication error |
Difficult insertion | Difficulty with lead placement |
Difficult removal | Difficulty with lead removal |
Procedural complications | |
Neurologic symptoms | New or worsened neurologic symptoms which most commonly involve numbness, paresthesias, weakness, or pain not including musculoskeletal back pain at entry points* |
Dural puncture | Visualized cerebrospinal fluid, suspected dural puncture, postdural puncture symptoms |
Infection | Infectious symptoms associated with non-prophylactic treatment |
Hematoma | Abnormal collection of blood |
Patient complaints | |
IPG site pain | Abnormal patient-reported discomfort at IPG site |
Unwanted stimulation | Inappropriate or overstimulation, electrical shock-like sensations, or stimulation in an unwanted area |
Surgically managed complications | |
Explant | Removal of all implanted components† |
Revision | Removal of any implanted component |
Serious adverse event | Epidural abscess, meningitis, seizure, asystole/cardiac arrest, stroke, death, neuraxial hematoma, admission to long-term rehabilitation, deep venous thrombosis, laminectomy/decompression surgery |
Other | Events not included in the above definitions |
Not including symptoms which were stimulation related and ceased upon decreasing or eliminating stimulation.
Removal of trials leads was not considered an explant.
IPG, implantable pulse generator.